Genolution Inc. (KOSDAQ:225220)

South Korea flag South Korea · Delayed Price · Currency is KRW
1,927.00
+9.00 (0.47%)
At close: Jan 27, 2026
-29.41%
Market Cap33.78B -14.2%
Revenue (ttm)9.15B +25.6%
Net Income-8.06B
EPS-446.41
Shares Out18.07M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume61,291
Average Volume100,386
Open1,918.00
Previous Close1,918.00
Day's Range1,899.00 - 1,934.00
52-Week Range1,824.00 - 3,030.00
Beta0.15
RSI41.65
Earnings DateMar 20, 2026

About Genolution

Genolution Inc. manufactures and sells IVD products in South Korea and internationally. Its products are primarily focused on molecular diagnostics, ribonucleic acid interference (RNAi) services, and dsRNA research for the prevention of breeding and extermination. The company offers Nextractor, an automatic extraction system for isolation of DNA or RNA from various samples; and FFPE, whole blood, buccal swab, RV, TB/NTM, STD, HPV, HBV, and CMV/EBV extraction kits, as well as rice, plant, and cell extraction kits. It also provides siRNA/shRNA sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2006
Employees 75
Stock Exchange KOSDAQ
Ticker Symbol 225220
Full Company Profile

Financial Performance

In 2024, Genolution's revenue was 7.14 billion, a decrease of -26.90% compared to the previous year's 9.76 billion. Losses were -6.83 billion, 23.8% more than in 2023.

Financial Statements